Diffuse Interstitial Pulmonary Fibrosis

  • Marvin I. Schwartz
  • David Lynch

Abstract

Histiocytosis X is a systemic disease characterized by the proliferation and infiltration of Langerhans’ cells in various organs [1–4]. The disease can manifest as an isolated disorder (i.e., eosinophilic granuloma of lung or bone) or as a systemic disease with multiple involvement including the skeletal, lung, reticuloendothelial system, skin and genitourinary system. The disseminated forms are more likely to appear in children and adolescents. In adults, disease isolated to lung is most common. There are some adult cases of eosinophilic granuloma of the lung in which skeletal and posterior pituitary gland involvement are present. However, systemic dissemination of histiocytosis X is less common in the adult populations. Furthermore, although the disseminated forms are more apt to occur in younger individuals, isolated organ involvement can also occur. There is sufficient evidence to suggest that the systemic forms of histiocytosis X are clonal neoplastic disorders of the Langerhans’ cell, thereby differentiating the systemic from the localized forms [2]. Most adult forms of histiocytosis X fall into the category of eosinophilic granuloma of the lung also referred to as Langerhans’ cell granulomatosis of the lung or pulmonary histiocytosis X.

Keywords

Lymphoma Respiration Carbon Monoxide Progesterone Cyclophosphamide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    1.Hance AJ, Cadranel J, Soler P et al. (1988) Pulmonary and extra pulmonary Langerhan cell granulomatosis (Histiocytosis X). Semin Respir Med 9: 349–68.Google Scholar
  2. 2.
    Willman CL, Busqué L, Griffith BB et al. (1994) Langerhans’ cell histiocytosis (histiocytosis X) - a clonal proliferative disease. N Engl J Med 331: 154–60.PubMedGoogle Scholar
  3. 3.
    Basset F, Corrin B, Spencer H et al. (1978) Pulmonary histiocytosis X. Am Rev Respir Dis 118: 811–19.PubMedGoogle Scholar
  4. 4.
    Friedman PJ, Liebow AA, Sokoloff J (1981) Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine 60: 385–96.PubMedGoogle Scholar
  5. 5.
    Basset F, Soler P, Wyllie L et al. (1976) Langerhans cells and lung interstitium. Ann NY Acad Sci 278: 599–611.PubMedGoogle Scholar
  6. 6.
    Basset F, Soler P, Jaurand MC et al. (1977) Ultrastructural examination of bronchoalveolar lavage for diagnosis of pulmonary histiocytosis X. Thorax 32: 303–6.PubMedGoogle Scholar
  7. 7.
    Travis WD, Borok Z, Roum JH et al. (1993) Pulmonary Langerhans’ cell granulomatosis (histiocytosis X): a clinicopathologic study of 48 cases. Am J Surg Pathol 17: 971–86.PubMedGoogle Scholar
  8. 8.
    Kawanami O, Basset F, Ferrans VJ et al. (1980) Pulmonary Langerhans’ cells in patients with fibrotic lung disorders. Lab Invest 44: 227–33.Google Scholar
  9. 9.
    Auerswald V, Barth J, Magnussen H (1991) Value of CD-I positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X. Lung 169: 305–9.PubMedGoogle Scholar
  10. 10.
    Murphy GF, Bhan AK, Sato S et al. (1981) A new immunologic marker for human Langerhans’ cells. N Engl J Med 304: 791–2.PubMedGoogle Scholar
  11. 11.
    Soller P, Chollet S, Jacque C et al. (1985) Immunocytochemical characterization of pulmonary histiocytosis X cells in lung biopsies. Am Pathol 118: 439–51.Google Scholar
  12. 12.
    Cocchia D, Michetti F, Donato R (1981) Immuno-chemical and immunocytochemical localization of S-100 antigen in normal human skin. Nature 294: 85–7.PubMedGoogle Scholar
  13. 13.
    Casolaro MA, Bernaudin JF, Saltini C et al. (1988) Accumulation of Langerhans’ cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. Am Rev Respir Dis 137: 406–11.PubMedGoogle Scholar
  14. 14.
    Soler P, Moreau A, Bassett F et al. (1989) Cigarette smoking induced charges in the number and differ-entiated state of pulmonary dendritic cells/ Langerhans’ cells. Am Rev Respir Dis 139: 1112–17.PubMedGoogle Scholar
  15. 15.
    Aguayo SM, Kane MA, King TE et al. (1989) Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic smokers. J Clin Invest 84: 1105–13.PubMedGoogle Scholar
  16. 16.
    Aguayo SM, King TE, Waldron JA et al. (1990) Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma. J Clin Invest 86: 838–44.PubMedGoogle Scholar
  17. 17.
    Auld D (1957) Pathology of eosinophilic ganuloma of lung. Arch Pathol 63: 113–31.Google Scholar
  18. 18.
    Lewis JG (1964) Eosinophilic granuloma and its variants with special reference to lung involvement: a report of 12 patients. Q J Med 131: 337–59.Google Scholar
  19. 19.
    Kulwiec E, Lynch D, Aguayo S et al. (1992) Imaging of Pulmonary Histiocytosis S. Radiographics 12: 515–26.PubMedGoogle Scholar
  20. 20.
    Grenier P, Valeyre D, Cluzel P et al. (1991) Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high resolution CT. Radiology 179: 123–32.PubMedGoogle Scholar
  21. 21.
    Brauner MW, Grenier P, Mouelhi MM et al. (1989) Pulmonary histiocytosis X: evaluation with high- resolution CT. Radiology 172: 255–8.PubMedGoogle Scholar
  22. 22.
    Moore A, Godwin J, Muller N et al. (1989) Pulmonary histiocytosis S: Comparison of radiographic and CT findings. Radiology 172: 249–54.PubMedGoogle Scholar
  23. 23.
    Taylor DB, Joske D, Anderson J et al. (1990) Cavitating pulmonary nodules in histiocytosis-X high resolution CT demonstration. Australas Radiol 34: 253–5.PubMedGoogle Scholar
  24. 24.
    Chusid EL (1966) Pulmonary eosinophilic granuloma. Aspects of pulmonary function. Mt. Sinai Hosp J 33: 116.Google Scholar
  25. 25.
    Hoffman L, Cohn JE, Guenster EA (1961) Respiratory abnormalities in eosinophilic granuloma of the lung. Long term study of five cases. N Engl J Med 267: 377–589.Google Scholar
  26. 26.
    Crausman RS, Jennings CA, Tuder RM et al. (1996) Pulmonary histiocytosis X: Pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med 153: 426–35.PubMedGoogle Scholar
  27. 27.
    Weinberger SE, Kelman JA, Elson NA et al. (1978) Bronchoalveolar lavage fluid in interstitial lung disease. Ann Intern Med 89: 459–66.PubMedGoogle Scholar
  28. 28.
    Housini I, Tomashefski JF, Cohen A et al. (1994) Transbronchial biopsy in patients with pulmonary eosinophilic granuloma: comparison with findings in open lung biopsy. Arch Pathol Lab Med 118: 523–30.PubMedGoogle Scholar
  29. 29.
    Delobbe A, Durieu J, Duhamel A et al. (1996) Determination of survival in pulmonary Langerhan’s cell granulomatosis. Eur Respir J 9: 2002–6.PubMedGoogle Scholar
  30. 30.
    von Essen S, West W, Sitorius M et al. (1990) Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Chest 98: 765–7.Google Scholar
  31. 31.
    Shonfeld N, Frank W, Wenig S et al. (1993) Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration 60: 38–44.Google Scholar
  32. 32.
    Benyounes B, Crestani B, Couveland A et al. (1996) Steroid-responsive pulmonary hypertension in a patient with Langerhan’s cell granulomatosis (histi-ocytosis X). Chest 110: 284–6.PubMedGoogle Scholar
  33. 33.
    Taylor JR, Ryu J, Colby TV et al. (1990) Lymph- angioleiomyomatosis: clinical course in 32 patients. N Engl J Med 323: 1254–60.PubMedGoogle Scholar
  34. 34.
    Corrin B, Liebow AA, Friedman PJ (1975) Pulmonary lymphangiomyomatosis: A review. Am J Pathol 79: 348–82.PubMedGoogle Scholar
  35. 35.
    Allaf DE, Borlee G, Hadjouj H et al. (1984) Pulmonary lymphangiomyomatosis. Eur J Respir Dis 65: 147–52.PubMedGoogle Scholar
  36. 36.
    Tazelaar HD, Kerr D, Yousem SA et al. (1993) Diffuse pulmonary lymphangiomatosis. Hum Pathol 24: 1313–22.PubMedGoogle Scholar
  37. 37.
    Kitaichi M, Nishimura K, Itott H et al. (1995) Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am Respir Crit Care Med 151: 527–33.Google Scholar
  38. 38.
    Bernstein SM, Newell JD, Adamczy KD et al. (1995) How common are renal angiomyolipomas in patients with pulmonary lymphangioleiomyomatosis? Am J Respir Crit Care Med 152: 2138–43.PubMedGoogle Scholar
  39. 39.
    Aberle Dr, Hansell DM, Brown K et al. (1990) Lymphangiomyomatosis: CT, chest radiographic, and functional correlations. Radiology 176: 381–7.PubMedGoogle Scholar
  40. 40.
    Horwitz T, Friedman L (1991) Findings on computed tomography of the chest in lymphangiomyomatosis. S Afr Med J 79: 53–4.PubMedGoogle Scholar
  41. 41.
    Lenoir S, Grenier P, Brauner MW et al. (1990) Pulmonary lymphangiomyomatosis and tuerous sclerosis: comparison of radiographc and thin- section CT findings. Radiology 175: 329–34.PubMedGoogle Scholar
  42. 42.
    Muller NL, Chiles C, Kullnig P (1990) Pulmonary lymphangiomyomatosis: correlation of CT with radiographic and functional findings. Radiology 175: 335–9.PubMedGoogle Scholar
  43. 43.
    Crausman R, Lynch D, Mortenson R et al. (1996) Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomymomatosis. Chest 109: 131–7.PubMedGoogle Scholar
  44. 44.
    Bernstein S, Adamczyk D, Mortenson R, Jr TK, Lynch D (1995) How common are renal angiomy-olipomas in patients with pulmonary lymphan-giomyomatosis? Am J Respir Crit Care Med 152: 2138–43.PubMedGoogle Scholar
  45. 45.
    Crausman RS, Jennings CA, Mortenson RL et al. (1996) Lymphangioleiomyomatosis: the pathophys-iology of diminished exercise capacity. Am J Respir Crit Care Med 153: 1368–76.PubMedGoogle Scholar
  46. 46.
    Carrington CB, Cugell DW, Gaensler EA et al. (1977) Lymphangioleiomyomatosis. Physiologic pathologie-radiologie correlations. Am Rev Respir Dis 116: 977–95.PubMedGoogle Scholar
  47. 47.
    Shen A, Iseman MD, Waldron JA et al. (1987) Exacerbation of pulmonary lymphangioleiomy-omatosis by exogenous estrogens. Chest 91: 782–4.PubMedGoogle Scholar
  48. 48.
    McCarty KS, Jr, Mossier JA, McLelland R et al. (1980) Pulmonary lymphangiomyomatosis responsive to progesterone. N Engl J Med 303: 1461–5.PubMedGoogle Scholar
  49. 49.
    Yockey CC, Riepe RE, Ryan K (1986) Pulmonary lymphangioleiomyomatosis complicated by preg-nancy. Kans Med 87: 277–93.PubMedGoogle Scholar
  50. 50.
    Sawicka ETT, Morris AJR (1985) A report of two long standing cases of pulmonary lymphang- iolieomyomatosis and the response to progesterone therapy. Br J Dis Chest 79: 400–16.PubMedGoogle Scholar
  51. 51.
    Svendsen TL, Viskum K, Hansborg N et al. (1984) Pulmonary lymphangioleiomyomatosis: a case of progesterone receptor positive lymphangioleiomy-omatosis leison treated with medroxyprogesterone, oophorectomy and tamoxifen. Br J Dis Chest 78: 264–71.PubMedGoogle Scholar
  52. 52.
    Banner AS, Carrington CB, Emory WB et al. (1981) Efficacy of oophorectomy in lymphangioleiomy-omatosis and benign metastasizing leiomyoma. N Engl J Med 305: 204–9.PubMedGoogle Scholar
  53. 53.
    Adamson D, Heinrichs WL, Raybin DM et al. (1985) Successful treatment of pulmonary lymphangiomy-omatosis with oophorectomy and progesterone. Am Rev Respir Dis 132: 916–21.PubMedGoogle Scholar
  54. 54.
    Eliasson AH, Phillips YY, Tenholder MF (1989) Treatment of lymphoangioleiomyomatosis. Chest 196: 1352–5.Google Scholar
  55. 55.
    Boehler A, Speich R, Russi EW et al. (1996) Lung transplantation for lymphoangioleiomyomatosis. N Engl J Med 335: 1275–80.PubMedGoogle Scholar
  56. 56.
    O’Brien JD, Lium JH, Parosa JF et al. (1995) Lymphangioleiomyomatosis recurrance in the allograft after single-lung transplantation. Am J Respir Crit Care Med 151: 2033–6.PubMedGoogle Scholar
  57. 57.
    Marshall D, Saul GB, Sach E (1959) Tuberous sclero-sis. A report of 16 cases in two family trees revealing genetic dominance. N Engl J Med 261: 1102–3.PubMedGoogle Scholar
  58. 58.
    Jin F, Wienecke R, Xiao GH et al. (1996) Suppression of tumorgenicity by the wild type tuberous sclerosis 2(Tsc2) gene and its C-terminal region. Proc Natl Acad Sei USA 93: 9154–9.Google Scholar
  59. 59.
    Dwyer JH, Hickie JB, Garvan J (1971) Pulmonary tuberous sclerosis: report of three patients and a review of the literature. Q J Med 40: 115–25.PubMedGoogle Scholar
  60. 60.
    Rosenberg DM (1982) Inherited forms of interstitial lung disease. Clin Chest Med 3: 635–41.PubMedGoogle Scholar
  61. 61.
    Aughenbaugh GL (1984) Thoracic manifestations of neurocutaneous diseases. Radiol Clin of N America 22: 741–56.Google Scholar
  62. 62.
    Medley BE, McLeod RA, Houser OW (1976) Tuberous sclerosis. Semin Roentgenol 11: 35–54.PubMedGoogle Scholar
  63. 63.
    Castro M, Shepard CW, Gomez MR et al. (1995) Pulmonary tuberous sclerosis. Chest 107: 189–95.PubMedGoogle Scholar
  64. 64.
    Riccardi VM (1981) von Recklinghausens neuro-fibromatosis. N Engl J Med 305:1616–27.Google Scholar
  65. 65.
    Webb WR, Goodman PC (1977) Fibrosing alveolitis in patients with neurofibromatosis. Radiology 122: 289–93.PubMedGoogle Scholar
  66. 66.
    Shimizu Y, Tsuchiya A, Watanabe S etal. (1994) von-Recklinghausen’s disease with lung cancer derived from the wall of emphysematous bullae. Int Med 33: 167–71.Google Scholar
  67. 67.
    Volpini E, Conuertino G, Fulgoni P et al. (1996) Pulmonary changes in a man affected by von- Recklinghausen’s disease. Minaldi Arch of Chest Dis 51: 123–4.Google Scholar
  68. 68.
    Scheerder ID, Elinck W, Renterghem DV et al. (1984) Desquamative interstitial pneumonia and scar cancer of the lung complicating generalized neurofibromatosis. Eur J Respir Dis 65: 623–6.PubMedGoogle Scholar
  69. 69.
    Patchefsky AS, Atkinson WG, Hoch WS et al. (1973) Interstitial pulmonary fibrosis and von- Recklinghausen’s disease: an ultrastructural and immunofluorescent study. Chest 64: 459–64.PubMedGoogle Scholar
  70. 70.
    Liebow AA, Steer A, Billingsley JG (1965) Desquamative interstitial pneumonia. Am J Med 59: 369–404.Google Scholar
  71. 71.
    Scadding JG (1974) Diffuse pulmonary alveolar fibrosis of the thorax. 29: 271–81.Google Scholar
  72. 72.
    Tubbs RR, Benjamin SP, Reich NE et al. (1977) Desquamative interstitial pneumonitis: cellular phase of fibrosing alveolitis. Chest 72: 159–69.PubMedGoogle Scholar
  73. 73.
    Lougheed MD, Roos JO, Waddell WR et al. (1995) Desquamative interstitial pneumonitis and diffuse alveolar damage in textile workers: potential role of myxotoxins. Chest 108: 1196–2000.PubMedGoogle Scholar
  74. 74.
    Klocke RA, Augersum WS, Berman HH et al. (1967) Desquamative interstitial pneumonia: a disease with a wide clinical spectrum. Ann Int Med 66: 498–506.PubMedGoogle Scholar
  75. 75.
    McCann BG, Brewer DB (1974) A case of desquamative interstitial pneumonia progressing to honeycomb lung. J Pathol 112: 199–202.PubMedGoogle Scholar
  76. 76.
    Kuisk H, Sanchez JS (1969) Desquamative interstitial pneumonia and idiopathic diffuse pulmonary fibrosis. Am J Roentgen 107: 258–79.PubMedGoogle Scholar
  77. 77.
    Carrington CB, Gaensler EA, Coutu RE et al. (1978) N Engl J Med 298: 801–9.PubMedGoogle Scholar
  78. 78.
    Patchefsky AS, Fraimow MD, Hoch WS (1973) Desquamative interstitial pneumonia: pathologic findings and follow-up in 13 patients. Arch Intern Med. 132: 222–5.PubMedGoogle Scholar
  79. 79.
    Hartman TE, Primack SL, Sensen SJ et al. (1993) Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 187: 787–90.PubMedGoogle Scholar
  80. 80.
    Hartman TE, Primack SL, Kang EY et al. (1996) Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT. Chest 110: 378–82.PubMedGoogle Scholar
  81. 81.
    Allen JN, Davis WB (1994) Eosinophilic lung diseases. Am J Respir Crit Care Med 150: 1423–38.PubMedGoogle Scholar
  82. 82.
    Badesch DB, King TE, Schwarz MI (1989) Acute eosinophilic pneumonia: a hypersensitivity phe-nomenon? Am Rev Respir Dis 139: 249–52.PubMedGoogle Scholar
  83. 83.
    Allen JN, Pacht ER, Gadek JE et al. (1989) Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 321: 569–74.PubMedGoogle Scholar
  84. 84.
    Buchheit J, Eid N, Rodgers G, Jr, et al. (1992) Acute eosinophilic pneumonia with respiratory failure: a new syndrome? Am Rev Respir Dis 145: 716–8.PubMedGoogle Scholar
  85. 85.
    St. John R, Allen JN, Pacht ER (1990) Acute eosinophilic pneumonia as a cause of failure to wean from mechanical ventilation. Intensive Care Med 16:408–10.Google Scholar
  86. 86.
    Davis WB, Wilson HE, Wall RL (1986) Eosinophilic alveolitis in acute respiratory failure: a clinical marker for a non-infectious etiology. Chest 89: 7–10.Google Scholar
  87. 86.
    Carrington CB, Addington WW, Goff AM et al. (1969) Chronic eosinophilic pneumonia. N Engl J Med 280: 787–98.PubMedGoogle Scholar
  88. 88.
    Fox G, Seed WA (1980) Chronic eosinophilic pneumonia. Thorax 35: 870–80.Google Scholar
  89. 89.
    Jederlinic PJ, Sicillian L, Gaensler EA (1988) Chronic eosinophilic pneumonia: a report of 19 cases and a review of literature. Medicine 67: 154–62.PubMedGoogle Scholar
  90. 90.
    Naughton M, Fahy J, Fitzgerald MX (1993) Chronic eosinophilic pneumonia; A long-term follow-up of 12 patients. Chest 103: 162–5.PubMedGoogle Scholar
  91. 91.
    Wellor PF, Bubley (1994) The idiopathic hypereosinophilic syndrome. Blood 83: 2759–79.Google Scholar
  92. 92.
    Spry CJF, Davies J, Tai PC et al. (1983) Clinical features of fifteen patients with the hypereosinophilic syndrome. Quart J Med 205: 1–22.Google Scholar
  93. 93.
    Chusid JF, Dale DC, West BC et al. (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine 54: 1–27.PubMedGoogle Scholar
  94. 94.
    Parrillo JE, Borer JS, Henery WL et al. (1979) The cardiovascular manifestations of the hyper-eosinophilic syndrome. Prospective study of 26 patients, with review of the literature. Am J Med 67: 572–82.PubMedGoogle Scholar
  95. 95.
    Zielinski RM, Lawrence WD (1990) Interferon- alpha for the hypereosinophilic syndrome. Ann Intern Med 113: 716–8.PubMedGoogle Scholar
  96. 96.
    Zabel P, Schlaak M (1991) Cyclosporin for hyper-eosinophilic syndrome. Ann Hematol 62: 230–1.PubMedGoogle Scholar
  97. 97.
    Smit AJ, van Essen LH, de Vries EGE (1991) Successful long-term control of idiopathic hyper-eosinophilic syndrome with etoposide. Cancer 67: 2826–7.Google Scholar
  98. 98.
    Hinson KFW, Moon AJ, Plummer NS (1952) Broncho-pulmonary aspergillosis. A review and a report of eight new cases. Thorax 7: 317–33.PubMedGoogle Scholar
  99. 99.
    McAller R, Kroenert DB, Elder JF et al. (1981) Allergic bronchopulmonary disease caused by Curvularia lunata and Drechslera hawaiiensis. Thorax 36: 338–44.Google Scholar
  100. 100.
    Benatar SR, Allan B, Hewitson RP et al. (1990) Allergic bronchopulmonary stemphyliosis. Thorax 35: 515–8.Google Scholar
  101. 101.
    Pepys J, Faux JA, Longbottom JL et al. (1968) Candida albicans precipitins in respiratory disease in man. J Allergy 41: 305.PubMedGoogle Scholar
  102. 102.
    Rosenberg M, Patterson R, Mintzer R et al. (1977) Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 86: 405–14.PubMedGoogle Scholar
  103. 103.
    Patterson R, Greenberger PA, Halwig JM et al. (1986) Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 146: 916–8.PubMedGoogle Scholar
  104. 104.
    Ricketti AJ, Greenberger PA, Patterson R (1984) Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 74: 68–71.PubMedGoogle Scholar
  105. 105.
    Patterson R, Greenberger PA, Lee TM et al. (1987) Prolonged evaluation of patients with cortico-steroid-dependent asthma stage of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 80: 663–8.PubMedGoogle Scholar
  106. 106.
    Capewell S, Chapman BJ, Alexander F et al. (1989) Corticosteroid treatment and prognosis in pulmonary eosinophilia. Thorax 44: 925–9.PubMedGoogle Scholar
  107. 107.
    Churg J, Strauss L (1951) Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Path 27: 277–301.PubMedGoogle Scholar
  108. 108.
    Chumbley LC, Harrison EG, DeRemee RA (1977) Allergic granulomatosis and angiitis (Churg - Strauss syndrome): report and analysis of 30 cases. Mayo Clin Proc 52: 477–84.PubMedGoogle Scholar
  109. 109.
    Lanham JF, Elkon KB, Pusey CD et al. (1984) Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg - Strauss syndrome. Medicine 63: 65–81.PubMedGoogle Scholar
  110. 110.
    Churg J (1936) Allergic granulomatosis and granulomatous-vascular syndromes. Ann Allergy 21: 619–28.Google Scholar
  111. 111.
    Cooper BJ, Vacal E, Patterson R (1978) Allergic angiitis and granulomatosis: Prolonged remission induced by combined prednisone-azathioprine therapy. Arc Intern Med 138: 367–71.Google Scholar
  112. 112.
    MacFadyen R, Tron V, Keshmiri M et al. (1987) Allergic angiitis of Churg and Strauss syndrome. Response to pulse methylprednisolone. Chest 91: 629–31.PubMedGoogle Scholar
  113. 113.
    Mayo FR, Muller NL, Road J etal. (1982) Chronic eosinophilic pneumonia: CT findings in six cases. Am J Roentgenol 1989;153: 727–730.Google Scholar
  114. 114.
    Patterson R, Greenberger PA, Radin RC, Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann of Intern Med 96: 286–91.Google Scholar
  115. 115.
    Patterson R, Greenberger PA, Halwig JM et al. (1986) Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 146: 916–8.PubMedGoogle Scholar
  116. 116.
    Greenberger PA, Miller TP, Roberts M et al. (1993) Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. Ann Allergy 70: 333–8.PubMedGoogle Scholar
  117. 117.
    Neeld DA, Goodman LR, Gurney JW et al. (1990) Computerized tomography in the evaluation of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 142: 1200–5.PubMedGoogle Scholar
  118. 118.
    Crystal RG, Bitterman PB, Rennard SI et al. (1984) Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 310: 154–235.PubMedGoogle Scholar
  119. 119.
    Schwarz MI (1988) Idiopathic pulmonary fibrosis. West J Med 149: 199–203.PubMedGoogle Scholar
  120. 120.
    Coultas DB, Zumwalt RE, Black WC et al. (1994) The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 150: 967–72.PubMedGoogle Scholar
  121. 121.
    Johnston I, Britton J, Kinnear W etal. (1990) Rising mortality from cryptogenic fibrosing alveolitis. BMJ 301: 1017–21.Google Scholar
  122. 122.
    du Bois RM (1993) Idiopathic pulmonary fibrosis. Annu Rev Med 44: 441–50.PubMedGoogle Scholar
  123. 123.
    Schwarz MI, Dreisin RB, Pratt DS et al. (1978) Immunoflourescent patterns in the idiopathic inter-stitial pneumonias. J Lab Clin Med 91: 929–38.PubMedGoogle Scholar
  124. 124.
    Dreisen RB, Schwarz MI, Theofilopoulos AN et al. (1978) Circulating immune complexes in the idio-pathic interstitial pneumonias. N Engl J Med 298: 353–7.Google Scholar
  125. 125.
    Veda T, Ohta K, Suzuki N (1992) Yamguchi Metal. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 146: 266–70.Google Scholar
  126. 126.
    Hogg JC (1995) Epstein-Barr virus and cryptogenic fibrosing alveolitis. Thorax 50: 1232.PubMedGoogle Scholar
  127. 127.
    Iwai K, Mori T, Yamada N et al. (1994) Idiopathic pulmonary fibrosis: epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med 150: 670–75.PubMedGoogle Scholar
  128. 128.
    Raghu G, Hert R (1993) Interstitial lung diseases: genetic predisposition and inherited interstitial lung diseases. Semin Respir Med 14: 323–32.Google Scholar
  129. 129.
    Corrin B, Dewar A (1996) Pathogenesis of idiopathic interstitial pulmonary fibrosis. Ultrstructural Pathol 20: 369–71.Google Scholar
  130. 130.
    Lynch JPIII, Standiford TJ, Rolfe MW et al. (1992) Neutrophilic alveolitis in idiopathic pulmonary fibrosis: The role of inerleukin-8. Am Rev Respir Dis 145: 1433.PubMedGoogle Scholar
  131. 131.
    Standiford TJ, Rolfe MW, Kunkel SL etal. (1998) Altered production of regulation of monocyte chemoattractant protein-1 from pulmonary fibroblasts isolated from patients with idiopathic pul-monary fibrosis. J Immunol. In press.Google Scholar
  132. 132.
    Broekelmann TJ, Limper AH, Colby TV et al. (1991) Transforming growth factor-1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sei USA 88: 6642.Google Scholar
  133. 133.
    Nagaoka I, Trapnell BC, Crystal RG (1990) Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis. J Clin Invest 5: 2023.Google Scholar
  134. 134.
    Baumgartner KB, Samet JM, Stidley CA et al. (1997) Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 155: 242–8.PubMedGoogle Scholar
  135. 135.
    Hiwatari N, Shimura S, Sasaki T et al. (1991) Prognosis of idiopathic pulmonary fibrosis in patients with mucous hypersecretion. Am Rev Respir Dis 143: 182–5.PubMedGoogle Scholar
  136. 136.
    Katzenstein ALA, Myers JL, Mazur MT (1986) Acute interstitial pneumonia: a clinicopathologic ultra- structual and cell kinetic study. Am J Surg Path 10: 256–67.PubMedGoogle Scholar
  137. 137.
    Pratt D, Schwarz MI, May J et al. (1979) Rapidly fatal pulmonary fibrosis: the accelerated variant of acute interstitial pneumonitis. Thorax 34: 587–93.PubMedGoogle Scholar
  138. 138.
    Mathieson JR, Mayo JR, Staples CA et al. (1989) Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 171: 111–6.PubMedGoogle Scholar
  139. 139.
    Muller NL, Miller RR, Webb WR et al. (1986) Fibrosing alveolitis: CT-pathologic correlation. Radiology 160: 585–8.PubMedGoogle Scholar
  140. 140.
    Wells AU, Rubens MB, du Bois RM, Hansell DM (1993) Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. Am J Roentgenol 161: 1159–65.Google Scholar
  141. 141.
    Wells AU, Hansell DM, Rubens MB et al. (1993) The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis 148: 1076–82.PubMedGoogle Scholar
  142. 142.
    Lee J, Im JG, Ahn J et al. (1992) Fibrosing alveolitis: prognostic implication of ground-glass attenuation at high-resolution CT. Radiology 184: 451–4.PubMedGoogle Scholar
  143. 143.
    Terriff B, Kwan S, Chan-Yeung M et al. (1992) Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment at follow-up in 26 patients. Radiology 184: 445–9.PubMedGoogle Scholar
  144. 144.
    Johkoh T, Ikezoe J, Kohno N et al. (1994) High- resolution CT and pulmonary function test in collagen vascular disease: comparison with idiopathic pulmonary fibrosis. Eur J Radiol 18: 113–21.PubMedGoogle Scholar
  145. 145.
    Sampson C, Hansell DM (1992) The prevalence of enlarged mediastinal lymph nodes in asbestos- exposed individuals: a CT study. Clin Radiol 45: 340–2.PubMedGoogle Scholar
  146. 146.
    Bergin C, Castellino RA (1990) Mediastinal lymph node enlargement on CT scans in patients with usual interstitial pneumonitis. Am J Roentgenol 154: 251–4.Google Scholar
  147. 147.
    Chinet T, Jaubert F, Dusser D et al. (1990) Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis. Thorax 45: 675.PubMedGoogle Scholar
  148. 148.
    Keogh BA, Lakatos E, Price D et al. (1984) Importance of the lower respiratory tract in oxygen transfer: Exercise testing in patients with interstitial and destructive lung disease. Am Rev Respir Dis 129: s76.PubMedGoogle Scholar
  149. 149.
    Nugent KM, Peterson MW, Jolles H et al. (1989) Correlation of chest roentgenograms with pulmonary function and bronchoalveolar lavage in interstitial lung disease. Chest 96: 1224.PubMedGoogle Scholar
  150. 150.
    Drent M, Cobben NAM, Henderson RF et al. (1996) Usefulness of lactic acid dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J 9: 1736–42.PubMedGoogle Scholar
  151. 151.
    Labrune S, Chinet TH, Colligonon MA et al. (1994) Mechanisms of increased epithelial lung clearance of DPTA in diffuse fibrosing alveolitis. Eur Respir J 7: 651–6.PubMedGoogle Scholar
  152. 152.
    Rudd RM, Haslam PL, Turner-Warwick M (1981) Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis 124: 1–8.PubMedGoogle Scholar
  153. 153.
    Turner-Warwick M, Haslam PL (1987) The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 135: 26–34.PubMedGoogle Scholar
  154. 154.
    Costabel U, Matthys H (1981) Different therapies and factors influencing response to therapy in idiopathic diffuse fibrosing alveolitis. Respiration 42: 141.PubMedGoogle Scholar
  155. 155.
    O’Donnell K, Keogh B, Cantin A et al. (1987) Pharmacologic suppression of the neutrophil com-ponent of the alveolitis in idiopathic pulmonary fibrosis. Am Rev Respir Dis 136: 288.PubMedGoogle Scholar
  156. 156.
    Johnson MA, Kwan S, Snell NJC et al. (1989) Randomized controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination for cryptogenic fibrosing alveolitis. Thorax 44: 280.PubMedGoogle Scholar
  157. 157.
    Baughman RP, Lower EE (1992) Use of intermittent intravenous cyclophosphamide for idiopathic pul-monary fibrosis. Chest 102: 1090.PubMedGoogle Scholar
  158. 158.
    Raghu G, DePaso WJ, Cain K et al. (1991) Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo controlled trial. Am Rev Respir Dis 144: 291–9.PubMedGoogle Scholar
  159. 159.
    Alton EW, Johnson M, Turner-Warwick M (1989) Advanced cryptogenic fibrosing alveolitis: Preliminary report on treatment with cyclosporin A. Respir Med 83: 277.PubMedGoogle Scholar
  160. 160.
    Peters SG, McDougall JC, Douglas WW et al. (1993) Colchicine in the treatment of pulmonary fibrosis. Chest 103: 101.PubMedGoogle Scholar
  161. 161.
    Grossman RF, Frost A, Zamel N et al. (1990) Results of single-lung transplantation for bilateral pulmonary fibrosis. N Engl J Med 322: 727.PubMedGoogle Scholar
  162. 162.
    Rosen SH, Castleman B, Liebow AA (1958) Pulmonary alveolar proteinosis. N Engl J Med 258: 1123–42.PubMedGoogle Scholar
  163. 163.
    Honda Y, Takahashi H, Shijubo N et al. (1993) Surfactant protein A concentration in bronchopul-monary lavage fluids of patients with pulmonary alveolar proteinosis. Chest 103: 469–99.Google Scholar
  164. 164.
    Alberti A, Luisetti M, Braschie A et al. (1995) Bronchoalveolar lavage fluid composition in alveolar proteinosis: early changes after therapeutic lavage. Am J Respir Crit Care Med 154: 817–20.Google Scholar
  165. 165.
    Hattore A, Kuroki Y, Takahashi H et al. (1996) Surfactant protein A accumulating in the alveoli of patients with pulmonary alveolar proteinosis: oligomeric structure and interaction with lipids. Am J Respir Cell Mol Bio 14: 608–19.Google Scholar
  166. 166.
    Voss T, Shafer KP, Nielsen PF et al. (1992) Primary structure differences of human surfactant-associ- ated proteins isolated from normal and proteinosis lung. Biochim Biophys Acta 1138: 261–7.PubMedGoogle Scholar
  167. 167.
    Crouch E, Persson A, Chang D (1993) Accumulation of surfactant protein D in human pulmonary alveolar proteinosis. Am J Pathol 142: 241–8.PubMedGoogle Scholar
  168. 168.
    Ramirez RJ, Harlan WR Jr. (1968) Pulmonary alveolar proteinosis. Nature and origin of alveolar lipid. Am J Med 45: 502–12.PubMedGoogle Scholar
  169. 169.
    Nogee LM, De Mello DE, Dehner LP et al. (1993) Brief Report: Deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 328: 407–10.Google Scholar
  170. 170.
    Eldar M, Shoenfeld Y, Zaizov R et al. (1979) Pulmonary alveolar proteinosis associated with Fanconi’s anemia. Respiration 38: 177–9.PubMedGoogle Scholar
  171. 171.
    McEuen DD, Abraham JL (1978) Particulate con-centrations in pulmonary alveolar proteinosis. Environ Res 17: 334–49.PubMedGoogle Scholar
  172. 172.
    McCunney RJ, Godefroi R (1989) Pulmonary alveolar proteinosis and cement dust. J Occup Med 31: 233–7.PubMedGoogle Scholar
  173. 173.
    Buechner HA, Ansari A (1969) Acute silicopro- teinosis. Dis Chest 55: 274–84.PubMedGoogle Scholar
  174. 174.
    Suratt PM, Winn WC Jr., Brody AR et al. (1977) Acute silicosis in tombstone sandblasters. Am Rev Respir Dis 115: 521–9.PubMedGoogle Scholar
  175. 175.
    Miller RR, Churg AM, Hutcheon M et al. (1984) Pulmonary alveolar proteinosis and aluminum dust exposure. Am Rev Respir Dis 130: 312–15.PubMedGoogle Scholar
  176. 176.
    Lakshminarayan S, Schwarz MI, Stanford RE (1976) Unsuspected pulmonary alveolar proteinosis com-plicating acute myelogenous leukemia. Chest 69: 433–5.PubMedGoogle Scholar
  177. 177.
    Aymard J, Gyger M, Lavallee R et al. (1984) A case of pulmonary alveolar proteinosis complicating chronic myelogenous leukemia. A peculiar pathologic aspect of busulfan lung? Cancer 53: 954–6.PubMedGoogle Scholar
  178. 178.
    Green D, Dighe P, Ali NO et al. (1980) Pulmonary alveolar proteinosis complicating chronic myelo- gous leukemia. Cancer 46: 1763–6.PubMedGoogle Scholar
  179. 179.
    Cordonnier C, Fleury-Feith J, Escudier E et al. (1994) Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemia patients. Am J Respir Crit Care Med 149: 788–94.PubMedGoogle Scholar
  180. 180.
    Doyle AP, Balcerzak SP, Wells CL et al. (1963) Pulmonary alveolar proteinosis with hematologic disorders. Arch Intern Med 112: 940–6.PubMedGoogle Scholar
  181. 181.
    Israel RH, Magnussen CR (1989) Are AIDS patients at risk for pulmonary alveolar proteinosis? Chest 96: 641–2.PubMedGoogle Scholar
  182. 182.
    Ruben FL, Talamo TS (1986) Secondary pulmonary alveolar proteinosis occurring in two patients with AIDS. Am J Med 80: 1187–90.PubMedGoogle Scholar
  183. 183.
    Reyes JM, Putong PB (1980) Association of pul-monary alveolar lipoproteinosis with mycobacterial infection. Am J Clin Pathol 74: 478–85.PubMedGoogle Scholar
  184. 184.
    Clague HW, Wallace AC, Morgan WKC (1983) Pulmonary interstitial fibrosis associated with alveolar proteinosis. Thorax 38: 865–6.PubMedGoogle Scholar
  185. 185.
    Hudson AR, Halprin GM, Miller JA et al. (1974) Pulmonary interstitial fibrosis following alveolar proteinosis. Chest 65: 700–2.PubMedGoogle Scholar
  186. 186.
    Honda Y, Kataoka K, Hayashi H et al. (1989) Alteration of acidic phospholipids in bronchoalveo- lar lavage fluids of patients with pulmonary alveolar proteinosis. Clin Chem Acta 181: 11–18.Google Scholar
  187. 187.
    Sahu S, DiAugustine RP, Lynn WS (1976) Lipids found in pulmonary lavage of patients with alveolar proteinosis and in rabbitt lung organelles. Am Rev Respir Dis 114: 177–85.PubMedGoogle Scholar
  188. 188.
    Suzuki Y, Fujita Y, Kogishi K (1989) Reconstruction of tubular myelin from synthetic lipids and protein associated with pig pulmonary surfactant. Am Rev Respir Dis 140: 75–81.PubMedGoogle Scholar
  189. 189.
    Harris JO (1979) Pulmonary alveolar proteinosis. Abnormal in vitro function of alveolar macrophages. Chest 76: 156–9.PubMedGoogle Scholar
  190. 190.
    Golde DW (1979) Alveolar proteinosis and the overfed macrophage. Chest 76: 119–20.PubMedGoogle Scholar
  191. 191.
    Golde DW, Territo M, Finley TN et al. (1976) Defective lung macrophages in pulmonary alveolar proteinosis. Ann Intern Med 85: 304–9.PubMedGoogle Scholar
  192. 192.
    Harris JO (1979) Pulmonary alveolar proteinosis: Abnormal in vitro function of alveolar macrophages. Chest 76: 156–9.PubMedGoogle Scholar
  193. 193.
    Nugent KM, Pesanti EL (1983) Macrophage function in pulmonary alveolar proteinosis. Am Rev Respir Dis 127: 780–1.PubMedGoogle Scholar
  194. 194.
    Hoffman RM, Dauber JH, Rogers RM (1989) Improvement in alveolar macrophage migration after therapeutic whole lung lavage in pulmonary alveolar proteinosis. Am Rev Respir Dis 139: 1030–2.PubMedGoogle Scholar
  195. 195.
    Stratton JA, Sieger L, Wasserman K (1981) The immunoinhibitory activities of the lung lavage materials and sera from patients with pulmonary alveolar proteinosis (PAP). J Clin Immunol 5: 81–6.Google Scholar
  196. 196.
    Jones CC (1960) Pulmonary alveolar proteinosis with unusual complicating infections. Am J Med 29: 713–22.PubMedGoogle Scholar
  197. 197.
    Andriole VT, Ballas M, Wilson GL (1964) The association of nocardiosis and pulmonary alveolar proteinosis. Ann Intern Med 60: 266–75.PubMedGoogle Scholar
  198. 198.
    Sunderland WA, Campbell RA, Edwards MJ (1972) Pulmonary alveolar proteinosis and pulmonary cryptococcosis in an adolescent boy. J Pediatr 80: 450–6.PubMedGoogle Scholar
  199. 199.
    Ranchod M, Bissell M (1979) Pulmonary alveolar proteinosis and cytomegalovirus infection. Arch Pathol Lab Med 103: 139–42.PubMedGoogle Scholar
  200. 200.
    Newell JD, Underwood GH Jr., Russo DJ et al. (1984) Computed tomographic appearance of pulmonary alveolar proteinosis in adults. J Comput Tomogr 8: 21–9.PubMedGoogle Scholar
  201. 201.
    Godwin JD, Muller NL, Takasugi JE (1988) Pulmonary alveolar proteinosis: CT findings. Radiology 169: 609–13.PubMedGoogle Scholar
  202. 202.
    Murch CR, Carr DH (1989) Computed tomography appearances of pulmonary alveolar proteinosis. Clin Radiol 40: 240–3.PubMedGoogle Scholar
  203. 203.
    Hoffman RM, Rogers RM (1991) Serum and lavage lactic dehydrogenase isoenzymes in pulmonary alveolar proteinosis. Am Rev Respir Dis 143: 42–6.PubMedGoogle Scholar
  204. 204.
    Musuda T, Shurma S, Sasaki H et al. (1991) Surfactant apoprotein-A concentration in sputum for diagnosis of pulmonary alveolar proteinosis. Lancet 337: 580–2.Google Scholar
  205. 205.
    Martin RJ, Coalson JJ, Rogers RM et al. (1980) Pulmonary alveolar proteinosis: the diagnosis by segmental lavage. Am Rev Respir Dis 121: 819–25.PubMedGoogle Scholar
  206. 206.
    Rogers RM, Braunstein MS, Shuman JF (1972) Role of bronchopulmonary lavage in the treatment of respiratory failure: a review. Chest (Suppl) 62: 95S–106S.Google Scholar
  207. 207.
    Rogers RM, Szidon JP, Shelburne J et al. (1972) Hemodynamic response of the pulmonary circulation to bronchopulmonary lavage in man. N Engl J Med 286: 1230–3.PubMedGoogle Scholar
  208. 208.
    Carrington BC, Liebow AA (1966) Lymphocytic interstitial pneumonia (abstract). Am J Pathol 48: 36a.Google Scholar
  209. 209.
    Koss MN, Hochholzer L, Langloss JM et al. (1987) Lymphoid interstitial pneumonia: clinicopathological and immunopathologic findings in 18 cases. Pathology 19: 178–85.PubMedGoogle Scholar
  210. 210.
    Turner RR, Colby TV, Doggett RS (1984) Well differentiated lymphocytic lymphoma, a study of 47 patients with primary manifestation in the lung. Cancer 54: 2088–96.PubMedGoogle Scholar
  211. 211.
    Talal N, Bunim J (1964) The development of malignant lymphoma in the course of Sjogren’s syndrome. Am J Med 36: 529.PubMedGoogle Scholar
  212. 212.
    Reich NE, McCormack LJ, Van Orstand HS (1974) Pseudolymphoma of the lung. Chest 65: 424–7.PubMedGoogle Scholar
  213. 213.
    Malamou-Mitsi V, Tsai MM, Greer JP et al. (1992) Lymphoid interstitial pneumonitis not associated with HIV infection: Role of Epstein-Barr virus. Mod Pathol 5: 487–91.PubMedGoogle Scholar
  214. 214.
    Strimlan CV, Rosenow EC, III, Divertie MB et al. (1976) Pulmonary manifestations of Sjogren’s syn-drome. Chest 70: 354–61.PubMedGoogle Scholar
  215. 215.
    Alkhayer M, McCann BG, Harrison BDW (1988) Lymphocytic interstitial pneumonitis in association with Sjogren’s syndrome. Br J Dis Chest 82: 305–9.PubMedGoogle Scholar
  216. 216.
    Strimlan CV, Rosenow EC III, Weiland LH et al. (1978) Lymphocytic interstitial pneumonitis: a review of 13 cases. Ann Intern Med 68: 616–21.Google Scholar
  217. 217.
    Bonner H, Jr., Ennis RS, Greelhoed GW et al. (1973) Lymphoid infiltration and amyloidosis of lung in Sjogren’s syndrome. Arch Pathol 95: 42–4.PubMedGoogle Scholar
  218. 218.
    Anderson I, Talal N (1972) The spectrum of benign to malignant lymphoproliferation in Sjogren’s syndrome. Clin Exp Immunol 10: 199–204.PubMedGoogle Scholar
  219. 219.
    Deheinzelin D, Capelozzi VL, Kairalla RA et al. (1996) Interstitial lung disease in primary Sjogren’s syndrome: Clinical-pathologic evaluation and response to treatment. Am J Respir Crit Care Med 154: 794–9.PubMedGoogle Scholar
  220. 220.
    Perreault C, Coosineau S, D’Angelo G et al. (1985) Lymphoid interstitial pneumonia after allogeneic bone marrow transplantation. Cancer 55: 1–9.PubMedGoogle Scholar
  221. 221.
    Church JA, Hart I, Saxon A et al. (1981) Lymphoid interstitial pneumonitis and hypogammaglobulinemia in children. Am Rev Respir Dis 124: 491–6.PubMedGoogle Scholar
  222. 222.
    Joshi VV, Oleske JM, Minnelor AB et al. (1985) Pathologic pulmonary findings in children with the acquired immunodeficiency syndrome: a study of ten cases. Hum Pathol 16: 241–6.PubMedGoogle Scholar
  223. 223.
    Scott GB, Buck BE, Leterman JG et al. (1984) Acquired immunodeficiency syndrome in infants. N Engl J Med 310: 76–81.PubMedGoogle Scholar
  224. 224.
    Goldman, H.S., Ziprkowski MN, Charytan M etal. (1985) Lymphocytic interstitial pneumonitis in chil-dren with AIDS: a perfect radiographie-pathologie correlation. AJR 145: 868A.Google Scholar
  225. 225.
    Solai-Celigny P, Couderc LV, Herman D et al. (1985) Lymphoid interstitial pneumonitis in acquired immunodeficiency syndrome-related complex. Am Rev Respir Dis 131: 956–60.Google Scholar
  226. 226.
    Ichikawa Y, Kinoshita M, Koga T et al. (1994) Lung cyst formation in lymphocytic interstitial pneumonitis: CT features J Comput Assist Tomog 18: 745–8.Google Scholar

Copyright information

© Springer-Verlag London Limited 1999

Authors and Affiliations

  • Marvin I. Schwartz
  • David Lynch

There are no affiliations available

Personalised recommendations